Literature DB >> 7368458

Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.

D K Johnson, J E Pontes, R Izbicki, J M Pierce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7368458     DOI: 10.1007/bf00261383

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


× No keyword cloud information.
  11 in total

1.  Remission of melanoma with D.N.C.B. treatment.

Authors:  S Malek-Mansour
Journal:  Lancet       Date:  1973-09-01       Impact factor: 79.321

2.  Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.

Authors:  S H Pai; L Amaral; S Werthamer; F G Zak
Journal:  Invest Urol       Date:  1973-09

3.  Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene.

Authors:  W R Levis; K H Kraemer; W G Klingler; G L Peck; W D Terry
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

4.  Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.

Authors:  E Ertürk; S M Cohen; J M Price; G T Bryan
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

5.  Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.

Authors:  E Ertürk; S M Cohen; G T Bryan
Journal:  Cancer Res       Date:  1970-05       Impact factor: 12.701

6.  Identification of complement-receptor lymphocytes (B cells) in lymph nodes and tumor infiltrates.

Authors:  W J Catalona; R Mann; F Nime; C Potvin; J I Harty; D Gomolka; J C Eggleston
Journal:  J Urol       Date:  1975-12       Impact factor: 7.450

7.  The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.

Authors:  E Ertürk; J M Price; J E Morris; S Cohen; R S Leith; A M Von Esch; A J Crovetti
Journal:  Cancer Res       Date:  1967-11       Impact factor: 12.701

8.  Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil.

Authors:  J H Raaf; S E Krown; C M Pinsky; W Cunningham-Rundles; B Safai; H F Oettgen
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

9.  Immunotherapy of non-clinical vaginal cancer.

Authors:  D Guthrie; S Way
Journal:  Lancet       Date:  1975-12-20       Impact factor: 79.321

10.  Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.

Authors:  D L Lamm; S C Harris; R F Gittes
Journal:  Invest Urol       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.